Oklahoma City biotech startup seeks funding for clinical trials

Oklahoma City’s EpimedX trying to develop treatment for sickle cell disease, which affects more than 90,000 people in the United States.

BY BRIANNA BAILEY Published: January 10, 2013
Advertisement
;

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the United States.

“Sickle cell...

Oklahoman subscribers have access to this article. Unlock it below.

What is this? Learn more.

NewsOK.com has disabled the comments for this article.
Advertisement


Trending Now



AROUND THE WEB

  1. 1
    Conservative Activist Claims Women Paid The Same As Men Won't Find Husbands
  2. 2
    Report: Thunder to open playoffs on Saturday
  3. 3
    Former Sonics guard Gary Payton: Durant, Westbrook 'the new era'
  4. 4
    GOP consulting firm employee starts 'Boats 'N Hoes PAC'
  5. 5
    Why One Man Traveled Almost 3,000 Miles To Take On The Federal Government At A Ranch In Nevada
+ show more